Siemens AG’s big IPO is in the pipeline and due to begin trading March 16, 2018. They are making a big bet on selling equipment that analyzes blood and other medical samples. Ironically it’s a segment of their business that hasn’t enjoyed much success, and comes at the same time they launched a new diagnostics brand (Atellica) that is meant to replace older products that are also less than successful. Competitors Roche Holdings and Abbott Laboratories continue to outperform Siemens, so a lot is riding on this IPO bet.
Read more at Bloomberg